BRPI0602106B8 - process for preparing a product based on passionflower incarnata l. - Google Patents

process for preparing a product based on passionflower incarnata l.

Info

Publication number
BRPI0602106B8
BRPI0602106B8 BRPI0602106A BRPI0602106A BRPI0602106B8 BR PI0602106 B8 BRPI0602106 B8 BR PI0602106B8 BR PI0602106 A BRPI0602106 A BR PI0602106A BR PI0602106 A BRPI0602106 A BR PI0602106A BR PI0602106 B8 BRPI0602106 B8 BR PI0602106B8
Authority
BR
Brazil
Prior art keywords
passionflower
incarnata
product based
preparing
insomnia
Prior art date
Application number
BRPI0602106A
Other languages
Portuguese (pt)
Inventor
Francisco Pianowski Luiz
Original Assignee
Ache Laboratorios Farm S/A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ache Laboratorios Farm S/A filed Critical Ache Laboratorios Farm S/A
Priority to BRPI0602106A priority Critical patent/BRPI0602106B8/en
Priority to PCT/BR2007/000127 priority patent/WO2007137380A1/en
Publication of BRPI0602106A publication Critical patent/BRPI0602106A/en
Publication of BRPI0602106B1 publication Critical patent/BRPI0602106B1/en
Publication of BRPI0602106B8 publication Critical patent/BRPI0602106B8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

processo para preparação de um produto à base de passiflora incarnata l., produto farmacêutico, composição farmacêutica, usos e método de tratamento de ansiedade e insônia a presente invenção refere-se, de forma geral, a um produto farmacêutico em pó à base de passiflora incarnata l., substancialmente desprovido de alcalóides, que proporciona maior segurança ao paciente, com manutenção da ação farmacológica sobre ansiedade e insônia.process for preparing a product based on passionflower incarnata L., pharmaceutical product, pharmaceutical composition, uses and method of treating anxiety and insomnia The present invention generally relates to a powdered pharmaceutical product based on passionflower incarnata L., substantially devoid of alkaloids, which provides greater safety to the patient, with maintenance of the pharmacological action on anxiety and insomnia.

BRPI0602106A 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l. BRPI0602106B8 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
BRPI0602106A BRPI0602106B8 (en) 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l.
PCT/BR2007/000127 WO2007137380A1 (en) 2006-05-25 2007-05-24 Pharmaceutical product based on passiflora incarnata l., uses therefor and method to treat anxiety and insomnia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0602106A BRPI0602106B8 (en) 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l.

Publications (3)

Publication Number Publication Date
BRPI0602106A BRPI0602106A (en) 2008-01-15
BRPI0602106B1 BRPI0602106B1 (en) 2018-04-17
BRPI0602106B8 true BRPI0602106B8 (en) 2021-05-25

Family

ID=38778034

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0602106A BRPI0602106B8 (en) 2006-05-25 2006-05-25 process for preparing a product based on passionflower incarnata l.

Country Status (2)

Country Link
BR (1) BRPI0602106B8 (en)
WO (1) WO2007137380A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0801239A2 (en) * 2008-04-01 2009-11-17 Ache Lab Farmaceuticos Sa use of one or more benzopyranones, pharmaceutical composition and method for the prevention or treatment of monoamine oxidase-associated diseases, disorders and disorders
KR20150019505A (en) * 2013-08-14 2015-02-25 대화제약 주식회사 Pharmaceutical Compositions comprising flavone-6-C-glucose derivatives for treating or preventing neuropsychiatric disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59608686D1 (en) * 1995-03-06 2002-03-21 Emil Flachsmann Ag Waedenswil Process for the removal of undesirable lipophilic impurities and / or residues, which are contained in drinks or herbal preparations
CH693403A5 (en) * 1998-09-17 2003-07-31 Flachsmann Ag Emil A process for the removal of undesired toxic alkaloids from plants or from plant preparations.
ES2274163T3 (en) * 2003-12-04 2007-05-16 Cognis Ip Management Gmbh PREPARATION FOR APPLICATION (I) ORAL AND / OR TOPICS.

Also Published As

Publication number Publication date
WO2007137380A1 (en) 2007-12-06
BRPI0602106A (en) 2008-01-15
BRPI0602106B1 (en) 2018-04-17

Similar Documents

Publication Publication Date Title
BRPI0714539B8 (en) process for obtaining opioid extended release pharmaceutical dosage form
BRPI0908421C1 (en) stable solution of a pharmaceutical compound
BR112012009376B8 (en) solid pharmaceutical composition comprising a sglt-2 inhibitor and its pharmaceutical dosage form
BR112015030031A2 (en) skin care scarf and skin care article
CO6660423A2 (en) Compositions and methods to treat gaucher disease
BR112015000150A2 (en) controlled release abuse deterrent pharmaceutical compositions
CL2012000185A1 (en) Oxazine or oxazepine derived compounds, bace inhibitors; pharmaceutical composition comprising them; pharmaceutical combination; and its use for the treatment of cognitive impairment, amyloid neuropathy, or Alzheimer's disease.
ECSP10010289A (en) DOSAGE REGIME ASSOCIATED WITH INJECTABLE PALIPERIDONE ESTERS OF PROLONGED ACTION
NI200800207A (en) CYTOTOXIC AGENTS INCLUDING NEW DERIVATIVES OF TOMAIMYCIN
BR112015021856A2 (en) processes and intermediates for the preparation of a medicament
BR112012010706A2 (en) compound, pharmaceutical composition, pharmaceutical combination, use of a compound, and methods for treating a disease or condition, and for inhibiting bromodomain
CR20110103A (en) HETEROARILOS SUBSTITUTED
CL2012000702A1 (en) Use of an alpha-7 nicotinic acetylcholine receptor agonist for the treatment of dyskinesia associated with dopamine agonist therapy in Parkinson's disease.
CO6501190A2 (en) PCSK9 VACCINE
BRPI1006713A2 (en) retroreflective articles
BRPI1010970A2 (en) pharmaceutical solution, process for preparing a pharmaceutical solution and method for treating
ECSP12011585A (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
BR112015006393A2 (en) method for producing a fabric product, fabric product produced by a process, and treatment method
CO6382089A2 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES CAUSED BY A B-AMYLOID AND SINUCLEINOPATIAS
CU20130063A7 (en) PRODUCTION PROCESS OF CYCLIC DEPSIPEPTIDES
BR112012015202A2 (en) "Iota - and / or kappa-carrageenate together with a neuraminidase inhibitor, method for the prophylactic or therapeutic treatment of a symptom, condition or disease, pharmaceutical composition, and kit of parts."
CO6430429A2 (en) THERAPEUTIC APPLICATIONS OF QUINAZOLINODIONA DERIVATIVES
BR112014012459A2 (en) 2h-indazoles as ep2 receptor antagonists
BR112014021133A2 (en) compound; pharmaceutical composition; method for treating, administering and / or reducing the diseases or disorders, syndrome or conditions associated with calcium uptake receptor modulation; and process for the preparation of compound
BRPI0516663A (en) Bengamides having a substituted cyclocaprolactam, preparation process, compositions containing them and the use

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07C 227/28 , A61K 8/97

Ipc: A61K 36/185 (2006.01), A61P 25/22 (2006.01)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/05/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: "INPI NO 52402.002941/2022-72 ORIGEM: 14A VARA CIVEL FEDERAL DE SAO PAULO (TRF3) PROCESSO NO: NUP 01032.300031/2022-77 SUBJUDICE COM PEDIDO DE ANTECIPACAO DE TUTELA AUTOR: LUIZ FRANCISCO PIANOWSKI REU(S): ACHE LABOTATORIOS FARMACEUTICOS S/A E INSTITUTONACIONAL DA PROPRIEDADE INTELECTUAL"